Gilvetmab

Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.

E-SE® (Selenium, Vitamin E)

ZUPREVO™ 18% (tildipirosin)

For the treatment of BRD in cattle, and the control of respiratory disease in cattle at high risk of developing BRD.